Functional impact and health utility of anxiety disorders in primary care outpatients

Medical Care

Volumn 43, Issue 12, 2005, Pages 1164-1170

  Stein, Murray B ^a   Roy Byrne, Peter P ^b   Craske, Michelle G ^c   Bystritsky, Alexander ^c   Sullivan, Greer ^d   Pyne, Jeffrey M ^d   Katon, Wayne ^b   Sherbourne, Cathy D ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e RAND CORPORATION   (United States)

Author keywords

Anxiety disorders; Depressive disorders; Disability; Health utility; Impairment; Primary care

Indexed keywords

ANXIOLYTIC AGENT;

ABSENTEEISM; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; FEMALE; HEALTH STATUS; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTPATIENT; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

ABSENTEEISM; ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MULTIVARIATE ANALYSIS; OUTPATIENTS; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SOCIOECONOMIC FACTORS;

EID: 29444433256     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000185750.18119.fd     Document Type: Article

References (44)

1. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
2. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581-2590.
3. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation: overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145-153.
4. Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv. 2002;53:80-86.
5. Olfson M, Fireman B, Weissman MM, et al. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 1997;154:1734-1740.
6. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669-682.
7. Goodwin RD. Anxiety disorders and the onset of depression among adults in the community. Psychol Med. 2002;32:1121-1124.
8. Alonso J, Angermeyer MC, Bernert S, et al. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004:38-46.
9. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993;50:85-94.
10. Katz SJ, Kessler RC, Lin E, et al. Medication management of depression in the United States and Ontario. J Gen Intern Med. 1998;13:77-85.
11. Young AS, Klap R, Sherbourne CD, et al. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
12. Andrews G, Issakidis C, Sanderson K, et al. Utilizing survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry. 2004;184:526-533.
13. Issakidis C, Sanderson K, Corry J, et al. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychol Med. 2004;34:19-35.
14. Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry. 1996;57:11-18.
15. Walker EA, Katon W, Russo J, et al. Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry. 2003;60:369-374.
16. Katon WJ, Roy-Byrne PP, Russo J, et al. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry. 2002;59:1098-1104.
17. Rodriguez BF, Weisberg RB, Pagano ME, et al. Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders. Compr Psychiatry. 2004;45:129-137.
18. Ansseau M, Dierick M, Buntinkx F, et al. High prevalence of mental disorders in primary care. J Affect Disord. 2004;78:49-55.
19. Hollifield M, Katon W, Skipper B, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997;154:766-772.
20. Marcus SC, Olfson M, Pincus HA, et al. Self-reported anxiety, general medical conditions, and disability bed days. Am J Psychiatry. 1997;154:1766-1768.
21. Olfson M, Shea S, Feder A, et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med. 2000;9:876-883.
22. Nisenson LG, Pepper CM, Schwenk TL, et al. The nature and prevalence of anxiety disorders in primary care. Gen Hosp Psychiatry. 1998;20:21-28.
23. Roy-Byrne PP, Sherbourne CD, Craske MG, et al. Moving treatment research from clinical trials to the real world. Psychiatr Serv. 2003;54:327-332.
24. Roy-Byrne PP, Craske MG, Stein MB, et al. A randomized effectiveness trial of cognitive behavior therapy and medication for primary care panic disorder. Arch Gen Psychiatry. 2005;62:290-298.
25. Stein MB, Roy-Byrne PP, McQuaid JR, et al. Screening for panic disorder in primary care. Psychosom Med. 1999;61:359-364.
26. Connor KM, Kobak KA, Churchill E, et al. Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14:137-140.
27. Composite International Diagnostic Interview (CIDI) 2.1. Geneva: World Health Organization; 1997.
28. Reed V, Gander F, Pfister H, et al. To what degree does the Composite International Diagnostic Interview (CIDI) correctly identify DSM-IV disorders? Testing validity issues in a clinical sample. International Journal of Methods in Psychiatric Research. 1998;7:142-155.
29. Means-Christensen A, Sherbourne CD, Roy-Byrne P, et al. The Composite International Diagnostic Interview (CIDI-Auto): problems and remedies for diagnosing panic disorder and social phobia. Int J Methods Psychiatr Res. 2003;12:167-181.
30. Epping-Jordan J, Ustun B. The WHODAS II: leveling the playing field for all disorders. WHO Bulletin of Mental Health. 2000;6:5-6.
31. Ware JE, Kosinski M, Keller SD. How to Score the SF-12 Physical and Mental Health Summary Scales. Boston: New England Medical Center, The Health Institute; 1995.
32. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851-859.
33. US Department of Health and Human Services. The 2001 HHS Poverty Guidelines. 2001.
34. Stein MB. Public health perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65(suppl 13):3-7.
35. Kendler KS, Neale MC, Kessler RC, et al. Major depression and generalized anxiety disorder: same genes, (partly) different environments? Arch Gen Psychiatry. 1992;49:716-722.
36. Kessler RC, Ormel J, Demler O, et al. Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003;45:1257-1266.
37. Wang PS, Beck AL, Berglund P, et al. Effects of major depression on moment-in-time work performance. Am J Psychiatry. 2004;161:1885-1891.
38. Sherbourne CD, Wells KB, Meredith LS, et al. Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry. 1996;53:889-895.
39. Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13:873-884.
40. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes. 2003;1:4.
41. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiatry. 1999;56:897-904.
42. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;136:765-776.
43. Hofer TP, Zemencuk JK, Hayward RA. When there is too much to do. How practicing physicians prioritize among recommended interventions. J Gen Intern Med 2004;19:646-653.
44. Rollman BL, Herbeck BB, Reynolds CF, et al. A contemporary protocol to assist primary care physicians in the treatment of panic and generalized anxiety disorders. Gen Hosp Psychiatry. 2003;25:74-82.